The functional exercise capacity is correlated with global functioning in patients with schizophrenia

Acta Psychiatrica Scandinavica

Volumn 125, Issue 5, 2012, Pages 382-387

  Vancampfort, D ^a,b   Probst, M ^a,b   Scheewe, T ^c   Knapen, J ^a,b   De Herdt, A ^b   De Hert, M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b KU Leuven   (Belgium)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

6 minute walk test; Global assessment of functioning; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; BODY MASS; COGNITION; COGNITIVE DEFECT; DEPRESSION; EXERCISE; EXERCISE TEST; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL EXERCISE CAPACITY; FUNCTIONAL STATUS; GLOBAL ASSESSMENT OF FUNCTIONING; GLOBAL FUNCTIONING; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; NEGATIVE SYNDROME; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; SIX MINUTE WALK TEST; SMOKING; WALKING;

ADULT; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; WALKING;

EID: 84859845702     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2011.01825.x     Document Type: Article

References (38)

1. Filik R, Sipos A, Kehoe PG et al. The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand 2006;113:298-305.
2. Leucht S, Burhard T, Henderson J, Maj M, Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 2007;116:317-333.
3. De Hert M, Schreurs V, Vancampfort D, Van Winkel R. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry 2009;8:15-22.
4. Von Hausswolff-Juhlin Y, Bjartveit M, Lindström E, Jones P. Schizophrenia and physical health problems. Acta Psychiatr Scand 2009;119:S15-S21.
5. De Hert M, Correll CU, Bobes J et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 2011;10:52-77.
6. Hasnain M, Vieweg VWR. Do we truly appreciate how difficult it is for patients with schizophrenia to adapt a healthy lifestyle? Acta Psychiatr Scand 2011;123:409-410.
7. Strassnig M, Brar JS, Ganguli R. Nutritional assessment of patients with schizophrenia: a preliminary study. Schizophr Bull 2003;29:393-397.
8. Bobes J, Arango C, Garcia-Garcia M, Rejas J. Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res 2010;119:101-109.
9. Vancampfort D, Knapen J, Probst M et al. Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia. Psychiatry Res 2010;177:271-279.
10. Vancampfort D, Probst M, Sweers K, Maurissen K, Knapen J, De Hert M. Relationships between obesity, functional exercise capacity, physical activity participation and physical self perception in people with schizophrenia. Acta Psychiatr Scand 2011;123:423-430.
11. Van Winkel R, Moons T, Peerbooms O et al. MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study. Int Clin Psychopharmacol 2010;25:270-276.
12. Laursen TM, Munk-Olsen T, Nordentoft M, Mortensen PB. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 2007;68:899-907.
13. De Hert M, Schreurs V, Sweers K et al. Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review. Schizophr Res 2008;101:295-303.
14. Rummel-Kluge C, Komossa K, Schwarz S et al. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res 2010;123:225-233.
15. Tiihonen J, Lonnqvist J, Wahlbeck K et al. 11-year follow-up of mortality in patients with schizophrenia: a population based cohort study (FIN11 study). Lancet 2009;374:620-627.
16. De Hert M, Dekker JM, Wood D, Kahl KG, Holt RIG, Möller H-J. Cardiovascular disease and diabetes is people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 2009;4:412-424.
17. De Hert M, Vancampfort D, Correll C et al. A systematic evaluation and comparison of the guidelines for screening and monitoring of cardiometabolic risk in people with schizophrenia. Br J Psychiatry 2011;199:99-105.
18. De Hert M, Bobes J, Cetkovich-Bakmas M et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, and recommendations at the system and individual levels. World Psychiatry 2011;10:138-151.
19. Mitchell AJ, Delafon V, Vancampfort D et al. Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychol Med 2011;42:125-147.
20. Strassnig M, Brar JS, Ganguli R. Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia. Schizophr Res 2011;126:103-109.
21. Vanhees L, Lefevre J, Philippaerts R et al. How to assess physical activity? How to assess physical fitness? Eur J Cardiovasc Prev Rehabil 2005;12:102-114.
22. AMERICAN THORACIC SOCIETY. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117.
23. Vancampfort D, Probst M, Maurissen K et al. Reliability, minimal detectable changes, practice effects and correlates of the six-minute walk test in patients with schizophrenia. Psychiatry Res 2011;187:62-67.
24. Beebe LH, Tian L, Morris N, Godwin A, Allen SS, Kuldau J. Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues Ment Health Nurs 2005;26:661-676.
25. Marzolini S, Jensen B, Melville P. Feasibility and effects of a group-based resistance and aerobic exercise program for individuals with severe schizophrenia: a multidisciplinary approach. Ment Health Phys Act 2009;2:29-36.
26. Vancampfort D, Sweers K, Probst M et al. The association of metabolic syndrome with physical activity performance in patients with schizophrenia. Diabetes Metab 2011;37:318-323.
27. Vancampfort D, Probst M, Scheewe T et al. Lack of physical activity during leisure time contributes to an impaired health related quality of life in patients with schizophrenia. Schizophr Res 2011;129:122-127.
28. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
29. Startup M, Jackson MC, Bendix S. The concurrent validity of the Global Assessment of Functioning (GAF). Br J Clin Psychol 2002;41:417-422.
30. Schwartz RC. Concurrent validity of the Global Assessment of Functioning Scale for clients with schizophrenia. Psychol Rep 2007;100:571-574.
31. De Hert M, Thys E, Vercrusyssen V. Partial hospitalization at night, the Brussels Nighthospital. Psychiatr Serv 1996;47:527-528.
32. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2009;41:459-471.
33. De Hert M, Bussel J, Lindstöm E, Abrahams F, Fransens C, Peuskens J. PECC, Psychosis Evaluation tool for Common use by Caregivers. Antwerpen: EPO, 1998.
34. De Hert M, Wampers M, Thys E, Wieselgren I, Lindstöm E, Peuskens J. Validation study of PECC (Psychosis Evaluation tool for Common use by Caregivers): interscale validity and inter-rater reliability. Int J Psychiatry Clin Pract 2002;6:135-140.
35. Gardner DM, Murphy AL, O'donnell H, Centorrino F, Baldessarani RJ. International consensus study of antipsychotic dosing. Am J Psychiatry 2010;167:686-693.
36. Surwillo W. Experimental design in psychiatry. Research methods for clinical practice. New York: Grune and Stratton, 1980.
37. Van Os J, Kapur S. Schizophrenia. Lancet 2009;374:635-645.
38. Vancampfort D, Knapen J, Probst M, Scheewe T, Remans S, De Hert M. A systematic review of correlates of physical activity in patients with schizophrenia. Acta Psychiatr Scand 2012;125:352-362.